Skip to content
Winnowleaf home

Berberine: What the Trials Show for Blood Sugar, Cholesterol and Weight, and Who Should Avoid It

Berberine, a plant compound sold as capsules, modestly lowered blood sugar in type 2 diabetes and LDL cholesterol in small trials, mostly from China (both grade B); its effect on weight is small and uncertain (grade C). No trial shows it can replace metformin or Ozempic. It raises the levels of some medicines, including cyclosporine, and must not be used in pregnancy, while breastfeeding or for newborns.

Published How we grade evidenceEditorial policy

Berberine is a bitter yellow compound from plants such as barberry, goldenseal and goldthread, sold as capsules. Most of its trials are small, short and run in China, in adults with type 2 diabetes, prediabetes or high cholesterol. Here is what they found, and the safety points that matter most.

The short version

  • Blood sugar in type 2 diabetes: in 37 trials (3,048 people), berberine alone or added to diabetes pills lowered fasting sugar by about 15 mg/dL, and in the 31 of them that measured it (2,683 people) HbA1c, a 3-month sugar average, by about 0.6 points; in 6 placebo-controlled trials of berberine alone, fasting sugar fell about 9 mg/dL. Grade B (Xie 2022; Liu 2025).
  • Against metformin: small, low-quality head-to-head trials found no clear difference in sugar control. Grade C (Yin 2008; Dong 2012). No published trial has compared it with Ozempic or any other GLP-1 drug (PubMed search, 9 November 2026).
  • Cholesterol: in 8 placebo-controlled trials LDL fell about 19 mg/dL, and in 9, triglycerides fell about 32 mg/dL, with very mixed results; HDL did not change. Grade B (Liu 2025; Zhang 2008).
  • Weight: BMI about 0.4 lower in 8 placebo-controlled trials, a change that lost statistical significance when 2 weaker trials were left out; waist about 3 cm smaller in 4 trials. Grade C (Liu 2025).
  • Safety: at 300 mg three times a day it slowed three liver enzymes that clear many medicines and raised levels of a test sedative by 40%, and it raised the transplant drug cyclosporine; never use it in pregnancy, while breastfeeding or for a newborn: in test-tube and rat studies it pushed bilirubin, the jaundice pigment, off its carrier protein, and NCCIH says it can harm newborns. Grade C for the drug effects (Guo 2012; Wu 2005; Chan 1993).
Question (who, compared with what)What trials foundSize of effectGrade
HbA1c, fasting sugar (type 2 diabetes; alone or added to diabetes pills)LowerHbA1c about 0.6 points (31 trials); fasting about 15 mg/dL (37 trials)B
Sugar control vs metformin (type 2 diabetes)No clear differenceSmall, low-quality trialsC
LDL, triglycerides (adults, berberine alone vs placebo)Lower; HDL unchangedLDL about 19 mg/dL; triglycerides about 32 mg/dLB
BMI, waist (adults, vs placebo)BMI slightly lower, not robust; waist smallerBMI about 0.4; waist about 3 cmC
Blood pressure (vs placebo)No change3 small trialsC
Drug levels (healthy men; cyclosporine in transplant patients)RaisedMidazolam 40%; cyclosporine trough 29%C (harm)

Does berberine lower blood sugar?

Grade B. A 2022 review pooled 37 randomized trials (3,048 adults with type 2 diabetes). Berberine was compared with placebo, no treatment or lifestyle advice, or added to diabetes pills and compared with the pills alone. Fasting sugar fell by 0.82 mmol/L (about 15 mg/dL) across the 37 trials, and HbA1c by 0.63 points in the 31 trials (2,683 people) that measured it (Xie 2022). A 2025 review that kept only placebo-controlled trials of berberine on its own found fasting sugar about 0.5 mmol/L (about 9 mg/dL) lower in 6 trials, which included people with prediabetes and polycystic ovary syndrome (PCOS), most of them run in China (Liu 2025). In a placebo-controlled trial, 116 adults with type 2 diabetes and high blood fats took 1 g a day for 3 months; fasting sugar, HbA1c and blood fats all ended lower than on placebo, and 5 people on berberine had constipation (Zhang 2008). This matches the grade in our blood sugar guide.

Berberine vs metformin: what the head-to-head trials show

Grade C: similar in small, low-quality trials. In a pilot trial, 36 adults with newly diagnosed type 2 diabetes took berberine or metformin, at the same dose three times a day, for 3 months; the authors reported a similar effect on blood sugar, with HbA1c falling from 9.5% to 7.5% in the berberine group (Yin 2008). A 2012 review of 14 trials found that berberine did not control sugar significantly better than metformin, glipizide or rosiglitazone, and that adding berberine to those pills did better than the pills alone, but it called the trials' quality generally low (Dong 2012). These trials lasted months, not years, and none measured heart attacks, kidney disease or other outcomes metformin is known for. Berberine is not a swap for a prescribed diabetes medicine.

Is berberine "nature's Ozempic"?

No. No published trial has compared berberine with semaglutide (Ozempic, Wegovy) or any other GLP-1 drug (PubMed search, 9 November 2026). The sizes are far apart: in a 68-week trial in adults with overweight or obesity, people on weekly semaglutide lost 14.9% of their weight, compared with 2.4% on placebo (Wilding 2021), while placebo-controlled berberine trials moved BMI by about 0.4 (Liu 2025). On a GLP-1 drug? See our GLP-1 medicines guide.

Does berberine help you lose weight?

Grade C: a small, fragile effect. In 8 placebo-controlled trials (684 adults), BMI was about 0.4 lower on berberine, but the drop lost statistical significance when the 2 lowest-quality trials were left out; waist size was about 3 cm smaller in 4 trials (396 adults), and that result held (Liu 2025). A larger 2026 review is not used, because its references include a retracted trial and one from a research group we exclude, and its weight result can't be checked without them. Our weight-loss guide gives the same grade C. See obesity and overweight.

Does berberine lower cholesterol?

Grade B: modest drops, with very mixed results between trials. In placebo-controlled trials of berberine alone, LDL cholesterol fell about 0.5 mmol/L (about 19 mg/dL) in 8 trials, total cholesterol about 0.45 mmol/L in 7, and triglycerides about 0.37 mmol/L (about 32 mg/dL) in 9; HDL did not change (Liu 2025). Our cholesterol guide gives berberine alone the same grade B from the same pool. Berberine is not a statin substitute.

Does berberine help PCOS, fatty liver or SIBO?

  • PCOS: grade C for lower testosterone, not for babies. In 8 trials (577 women), total testosterone was slightly lower with berberine, but 7 of them added berberine to another PCOS treatment (mostly a cyproterone hormone pill, metformin or a herbal medicine) and compared it with that treatment alone, and results varied widely (Xie 2019). In the one that tested berberine alone against placebo, in 150 women preparing for IVF, testosterone fell more on berberine than on placebo over 3 months (An 2014). Live births were no higher than with placebo or metformin, and lower than with the fertility drug letrozole (Xie 2019). See the PCOS guide.
  • Fatty liver: grade B for liver enzymes. In 10 trials (811 adults), liver enzymes and blood fats fell more than in the comparison groups. 6 of the 10 added berberine to metformin and compared it with metformin alone, 3 compared it with lifestyle advice alone, and one tested berberine ursodeoxycholate, an experimental drug that pairs berberine with the liver medicine ursodiol; only 2 were double-blind (Nie 2024). See fatty liver disease and our liver guide.
  • SIBO (small intestinal bacterial overgrowth): grade D. A 2025 network analysis of SIBO treatments ranked berberine first for clearing the overgrowth, but a ranking is not a measured effect, and its berberine data came from one 46-person interim report of a trial comparing berberine with the antibiotic rifaximin, which found no significant difference (Zhang 2025); that trial's design was published in 2023 (Guo 2023). See SIBO.
  • Blood pressure: in 3 small placebo-controlled trials, it did not change (Liu 2025).

Berberine, dihydroberberine or patches: does the form matter?

The trials above used berberine tablets or capsules by mouth, most often 500 mg two or three times a day; at these amounts it can cause constipation or stomach upset and change the levels of other medicines (Liu 2025; Guo 2012). Dihydroberberine, a related compound sold as better absorbed, has been tested only for blood levels: in a pilot crossover in 5 young men, it gave higher blood levels of berberine than standard berberine, with no clear difference in blood sugar (Moon 2021). No trial shows it works better.

What we'd skip

  • Berberine patches or "natural GLP-1" patches. A 2026 editorial found 24 transdermal patch supplements and 1 gel, with berberine among the most listed ingredients, with no posted test results and often deceptive advertising; US law says a dietary supplement must be swallowed, so the authors call these products illegal (White 2026).
  • Swapping metformin, a statin or a GLP-1 drug for berberine. The trials are short and small, and none measured heart or kidney outcomes.
  • Goldenseal as a berberine source. Very little berberine may be absorbed from goldenseal taken by mouth, so berberine results may not apply to it, and it shares berberine's newborn risk (NCCIH).

Safety and interactions

  • Stomach, bowel and blood sugar: low blood sugar, nausea, constipation and mild stomach discomfort were the most reported side effects in placebo-controlled trials; in a 2025 pooled analysis, stomach side effects on berberine and on placebo did not differ significantly (Liu 2025), but in the 116-person diabetes trial 5 people on berberine had constipation (Zhang 2008).
  • Medicines cleared by liver enzymes: 300 mg three times a day for 2 weeks slowed three enzymes (CYP2D6, CYP2C9 and CYP3A4) in healthy men and raised blood levels of midazolam, a sedative used as a test drug, by 40% (Guo 2012). The FDA lists, among medicines cleared by those enzymes, simvastatin, lovastatin and atorvastatin, the blood thinner warfarin, the transplant drugs tacrolimus and sirolimus, the diabetes pill glimepiride, the beta-blocker metoprolol, quetiapine and sildenafil (FDA). If you take one, ask your pharmacist before starting berberine.
  • Cyclosporine: in kidney transplant patients, cyclosporine trough levels ended 29% higher with berberine than without it (Wu 2005). Don't take berberine with cyclosporine unless your transplant team agrees.
  • Metformin and other diabetes medicines: berberine added to diabetes pills lowered sugar more than the pills alone (Dong 2012); of 9 trials that checked, only 2 (186 people) recorded any low-sugar episodes, so that risk is uncertain (Xie 2022). With insulin or a sulfonylurea such as glimepiride, check your sugar more often. Goldenseal, which contains berberine, cut metformin levels about 20% in adults with type 2 diabetes on low metformin doses (500 to 750 mg a day), and its authors advise caution (Nguyen 2025); in healthy adults the drop was about 25%, enough to potentially hinder sugar control (NCCIH). Ask your prescriber before adding goldenseal or berberine to metformin. More in can I take berberine with metformin?
  • Heart-rhythm and blood pressure medicines: a 2026 review of berberine interactions lists possible added effects on blood sugar, blood pressure and heart rhythm (QT interval) (Dumitru 2026). Ask your prescriber if you take a heart-rhythm medicine.
  • Liver and kidneys: the US liver-injury database says berberine has not been linked to liver enzyme rises or to clinically apparent liver injury (LiverTox); in the trials that checked, liver and kidney tests stayed normal (Liu 2025).
  • How much: no upper limit has been set. Trials mostly used 1 to 1.5 g a day in two or three doses for about 3 months (Liu 2025); at 0.9 g a day it already slowed drug-clearing enzymes (Guo 2012), and stomach upset is the common side effect at these amounts.
  • Pregnancy and newborns: don't use it. In test-tube and rat studies, berberine pushed bilirubin, the yellow pigment of newborn jaundice, off its carrier protein; huanglian, a herb rich in berberine, has been reported to pose a risk of kernicterus (brain damage from jaundice) in jaundiced newborns, and the study's author advises avoiding it in jaundiced newborns and pregnant women (Chan 1993). NCCIH says goldenseal's berberine can be harmful to newborns (NCCIH). Ask your midwife or obstetric team about blood sugar in pregnancy.
  • Breastfeeding? Don't take it: how much reaches milk is unknown, and most sources advise keeping newborns away from it (LactMed: Goldenseal). Ask your midwife, doctor or a lactation specialist, who can check what passes into breast milk.
  • Children: never give it to a newborn or baby; for older children, ask your child's doctor.

When to see a doctor

  • Emergency (911) for signs of very low blood sugar that don't settle with sugar, such as confusion, fainting or a seizure, or for yellow skin or eyes in a newborn whose parent took berberine.
  • Same day for shaking, sweating or a racing heart with low sugar readings, unusual bruising or bleeding on warfarin, or new drowsiness or dizziness after starting berberine with another medicine.
  • Soon if constipation or stomach pain lasts more than a few days, or if your sugar or cholesterol stays high.

Don't stop a prescribed medicine on your own; ask the prescriber or pharmacist. Pregnant or breastfeeding? Don't take berberine. Under 18? Check with a clinician first.

FAQ

Is berberine "nature's Ozempic"? No. No trial has compared them, and weekly semaglutide lowered weight by about 15% in a 68-week trial while berberine moved BMI by about 0.4 in placebo-controlled trials (grade C).

Is berberine as good as metformin? In small, low-quality trials, sugar control was similar (grade C), but none ran for years or measured heart or kidney outcomes. Don't swap one for the other without your prescriber.

Can I take berberine with metformin? Ask your prescriber first. Together they lowered sugar more than metformin alone, so check your sugar more often; see can I take berberine with metformin?

How long does berberine take to work? The trials measured sugar and cholesterol after about 1 to 3 months, so that is the time frame the evidence covers.

Is berberine safe? In trials of up to a few months, the most reported side effects were stomach upset, constipation and low blood sugar, and liver and kidney tests stayed normal. It changes the levels of some medicines, including cyclosporine, and must not be used in pregnancy, while breastfeeding or for newborns.

Sources

  1. Xie W, et al. Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Front Pharmacol. 2022. PubMed 36467075 · doi:10.3389/fphar.2022.1015045
  2. Liu D, et al. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Front Pharmacol. 2025. PubMed 40740996 · doi:10.3389/fphar.2025.1572197
  3. Yin J, et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008. PubMed 18442638 · doi:10.1016/j.metabol.2008.01.013
  4. Dong H, et al. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012. PubMed 23118793 · doi:10.1155/2012/591654
  5. Zhang Y, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008. PubMed 18397984 · doi:10.1210/jc.2007-2404
  6. Guo Y, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012. PubMed 21870106 · doi:10.1007/s00228-011-1108-2
  7. Wu X, et al. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol. 2005. PubMed 16133554 · doi:10.1007/s00228-005-0952-3
  8. Chan E. Displacement of bilirubin from albumin by berberine. Biol Neonate. 1993. PubMed 8513024 · doi:10.1159/000243932
  9. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. PubMed 33567185 · doi:10.1056/NEJMoa2032183
  10. Xie L, et al. The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials. Evid Based Complement Alternat Med. 2019. PubMed 31915452 · doi:10.1155/2019/7918631
  11. An Y, et al. The use of berberine for women with polycystic ovary syndrome undergoing IVF treatment. Clin Endocrinol (Oxf). 2014. PubMed 23869585 · doi:10.1111/cen.12294
  12. Nie Q, et al. The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review. J Transl Med. 2024. PubMed 38429794 · doi:10.1186/s12967-024-05011-2
  13. Zhang Q, et al. Comparative efficacy of diverse therapeutic regimens for small intestinal bacterial overgrowth: a systematic network meta-analysis. Ther Adv Gastroenterol. 2025. PubMed 41394885 · doi:10.1177/17562848251399033
  14. Guo H, et al. Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study). Front Pharmacol. 2023. PubMed 36873985 · doi:10.3389/fphar.2023.1121435
  15. Moon JM, et al. Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. Nutrients. 2021. PubMed 35010998 · doi:10.3390/nu14010124
  16. White CM, et al. Transdermal "Natural GLP-1" Dietary Supplements Violate Law and Place Patients at Risk. Ann Pharmacother. 2026. PubMed 41480958 · doi:10.1177/10600280251407145
  17. Nguyen JT, et al. The Pharmacokinetic Interaction Between Metformin and the Natural Product Goldenseal Is Metformin Dose-Dependent: A Three-Arm Crossover Study in Adults With Type 2 Diabetes. Clin Transl Sci. 2025. PubMed 39943692 · doi:10.1111/cts.70120
  18. Dumitru CN, et al. Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review. Pharmaceuticals (Basel). 2026. PubMed 42653808 · doi:10.3390/ph19081313
  19. National Institute of Diabetes and Digestive and Kidney Diseases. Berberine. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012. PubMed 33242239 · NCBI Bookshelf NBK564659
  20. National Institute of Child Health and Human Development. Goldenseal. Drugs and Lactation Database (LactMed). 2006. PubMed 30000926 · NCBI Bookshelf NBK501866